IP Library Granted Patent US 11,696,902
Granted Patent B2
US 11,696,902 · App. 16/693,310 · Granted Jul 11, 2023

Method of initiating and escalating sotalol hydrochloride dosing

Inventors: John Somberg (Chicago, IL); Brandon Ira Kashfian (Chicago, IL); Janos Molnar (Chicago, IL)
Assignee: AltaThera Pharmaceuticals, LLC
A61K31/136A61K9/0019A61K9/0053
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,696,902
App. No.
16/693,310
Granted
Jul 11, 2023
Kind
B2
Abstract

This disclosure provides a method of safely and rapidly initiating or escalating oral sotalol therapy by administering an intravenous dosage of sotalol followed by oral sotalol twice daily.

Claims (8)

1. A method of initiating oral sotalol hydrochloride therapy comprising:

identifying a subject as naïve to sotalol, having symptomatic atrial fibrillation or atrial flutter, and currently in sinus rhythm;

administering to the subject a single intravenous (IV) dosage of sotalol hydrochloride, over a period of 1 hour, wherein the single IV dosage comprises an amount of sotalol hydrochloride in the range of 116-141 mg;

after completion of the single IV dosage of sotalol hydrochloride, administering a first oral dosage of sotalol hydrochloride in the amount of 120 mg.

2. The method of claim 1 , wherein the first oral dosage is administered starting 4-6 hours after completion of the IV dosage.

3. The method of claim 2 , further comprising administering a second oral dosage, wherein the second oral dosage is administered 12 hours after the first oral dosage.

4. The method of claim 3 , further comprising administering one or more subsequent oral dosage at a 12-hour interval from the second oral dosage.

5. The method of claim 1 , wherein the single IV dosage comprises an amount of sotalol hydrochloride in the range of 121-141 mg.

Assignments (3)
ASSIGNMENT OF SECURITY INTEREST IN PATENT COLLATERAL Recorded Jul 14, 2023
From: SAGARD HEALTHCARE ROYALTY PARTNERS, LP
To: SAGARD HEALTHCARE PARTNERS (DELAWARE) LP
Reel/Frame 064275/0433 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2021
From: SOMBERG, JOHN CHARIN; KASHFIAN, BRANDON IRA; MOLNAR, JANOS
To: ALTATHERA PHARMACEUTICALS LLC
Reel/Frame 055820/0938 →
SECURITY INTEREST Recorded Feb 26, 2021
From: ALTATHERA PHARMACEUTICALS LLC
To: SAGARD HEALTHCARE ROYALTY PARTNERS, LP
Reel/Frame 055427/0934 →
Continuity (2)
Continuation In Part 16103815 · Aug 14, 2018
Related Publication 20200093759A1 · Mar 26, 2020
Cited By (4)
US 12,390,431 US 12,396,970 US 12,403,109 US 12,740,947